Article

HSO suspends clear-optic IOL sales

HOYA Surgical Optics, Inc. (HSO) announces that it has voluntarily suspended sales of two models of its clear-optic IOLs: the iSymm IOL (Model FC-60AD) and the iSert IOL (Model PC-60AD). This action affects only U.S. customers, and HSO has requested the return of these lenses.

Chino Hills, CA-HOYA Surgical Optics, Inc. (HSO) announces that it has voluntarily suspended sales of two models of its clear-optic IOLs: the iSymm IOL (Model FC-60AD) and the iSert IOL (Model PC-60AD). This action affects only U.S. customers, and HSO has requested the return of these lenses.

HSO has been working with the FDA to resolve an issue regarding the approval status of the clear-optic lenses, and believes that the regulatory process will be more efficient if the lenses are returned while it continues to work with the FDA.

“[The] FDA has informed us [that] they have not yet approved these lens models, and we have filed additional data as requested by them to obtain FDA approval. While we are disappointed [that] this recall is required, we remain strongly committed to our U.S. customers and believe that our actions demonstrate our intent to work closely with them and the FDA to provide the same outstanding products and services that have allowed us to become the fastest-growing IOL company in the U.S.,” said Steven L. Ziemba, HSO’s vice president of global regulatory affairs.

For assistance, customers can call HSO toll-free, at 866/750-5870.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.